choline has been researched along with Tremor in 15 studies
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
Excerpt | Relevance | Reference |
---|---|---|
"The bioavailability of three different theophylline tablets (microcrystallinic theophylline, Theolair, Nuelin, 3M Riker), choline theophyllinate as a new film-coated tablet (Teovent, Ferrosan, Sweden) and theophyllaminopropanol (Oxyphylline, Draco, Sweden) was investigated in eight adult asthmatics and a randomized, double-blind, cross-over study." | 9.05 | Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation. ( Mellstrand, T; Svedmyr, K; Svedmyr, N, 1982) |
"A peripheral and cerebral cholinergic syndrome was induced in mice by oxotremorine administration; pretreatment orally with cytidine diphosphocholine (CDP-choline) does not potentiate this syndrome and even antagonizes oxotremorine-induced salivation." | 7.67 | Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine. ( Boismare, F; Chadelaud, M; Chretien, P; Daoust, M; Moore, N; Saligaut, C, 1985) |
"The efficacy of an oral treatment of cytidine diphosphate choline (CDP-choline, citicoline, Somazina) is studied with reference to the effects on parasympathetic stimulation provoked by oxotremorine administration in mice." | 7.66 | Pharmacological study of oral CDP-choline. Interaction with oxotremorine on the parasympathetic system. ( Ortiz, JA; Sacristán, A; Tornos, ME, 1983) |
"The bioavailability of three different theophylline tablets (microcrystallinic theophylline, Theolair, Nuelin, 3M Riker), choline theophyllinate as a new film-coated tablet (Teovent, Ferrosan, Sweden) and theophyllaminopropanol (Oxyphylline, Draco, Sweden) was investigated in eight adult asthmatics and a randomized, double-blind, cross-over study." | 5.05 | Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation. ( Mellstrand, T; Svedmyr, K; Svedmyr, N, 1982) |
" However, no correlation was found between antistereotypic effect of neuroleptics and their ability to block 3H-quinuclidinyl benzylate binding or arecoline-induced tremor." | 3.67 | [Significance of the dopamine-blocking and m-choline-blocking components in the antiapomorphine action of neuroleptics]. ( Chereshka, KS; Langel, IuL; Zharkovskaia, TA; Zharkovskiĭ, AM, 1987) |
"The acute and chronic effects of the centrally active oxotremorine analog, BM-5, [N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)-acetamide] were examined in rats and mice." | 3.67 | BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies. ( Bartfai, T; Consolo, S; Engström, C; Ladinsky, H; Undén, A, 1987) |
"A peripheral and cerebral cholinergic syndrome was induced in mice by oxotremorine administration; pretreatment orally with cytidine diphosphocholine (CDP-choline) does not potentiate this syndrome and even antagonizes oxotremorine-induced salivation." | 3.67 | Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine. ( Boismare, F; Chadelaud, M; Chretien, P; Daoust, M; Moore, N; Saligaut, C, 1985) |
"The efficacy of an oral treatment of cytidine diphosphate choline (CDP-choline, citicoline, Somazina) is studied with reference to the effects on parasympathetic stimulation provoked by oxotremorine administration in mice." | 3.66 | Pharmacological study of oral CDP-choline. Interaction with oxotremorine on the parasympathetic system. ( Ortiz, JA; Sacristán, A; Tornos, ME, 1983) |
"Choline treatments could restore the membrane lipids, repair cellular organelles and protect mutant cells from acute iron overload." | 1.56 | Choline transporter-like 1 deficiency causes a new type of childhood-onset neurodegeneration. ( Agarwal, P; Bakovic, M; Brady, L; Distelmaier, F; Dolinsky, VW; Fagerberg, CR; Gade, E; Hejbøl, EK; Jamra, RA; Kibæk, M; Klee, D; Larsen, MJ; Markovic, L; Nagy, P; Rouse, N; Schrøder, HD; Seibt, A; Tarnopolsky, M; Taylor, A; Wieczorek, D, 2020) |
"A slowly progressive sensory ataxia and tremor manifested at the age of 3 to 16 years and distal spasticity in adolescence." | 1.32 | Five new cases of a recently described leukoencephalopathy with high brain lactate. ( Aärimaa, T; Autti, T; Häkkinen, AM; Koillinen, H; Kuusi, T; Linnankivi, T; Lönnqvist, T; Lundbom, N; Pihko, H; Sainio, K; Valanne, L, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (66.67) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 2 (13.33) | 29.6817 |
2010's | 1 (6.67) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Fagerberg, CR | 1 |
Taylor, A | 1 |
Distelmaier, F | 1 |
Schrøder, HD | 1 |
Kibæk, M | 1 |
Wieczorek, D | 1 |
Tarnopolsky, M | 1 |
Brady, L | 1 |
Larsen, MJ | 1 |
Jamra, RA | 1 |
Seibt, A | 1 |
Hejbøl, EK | 1 |
Gade, E | 1 |
Markovic, L | 1 |
Klee, D | 1 |
Nagy, P | 1 |
Rouse, N | 1 |
Agarwal, P | 1 |
Dolinsky, VW | 1 |
Bakovic, M | 1 |
Barbagallo, G | 1 |
Arabia, G | 1 |
Morelli, M | 1 |
Nisticò, R | 1 |
Novellino, F | 1 |
Salsone, M | 1 |
Rocca, F | 1 |
Quattrone, A | 2 |
Caracciolo, M | 1 |
Sabatini, U | 1 |
Cherubini, A | 1 |
Baik, HM | 1 |
Choe, BY | 1 |
Son, BC | 1 |
Jeun, SS | 1 |
Kim, MC | 1 |
Lee, KS | 1 |
Kim, BS | 1 |
Lee, JM | 1 |
Lee, HK | 1 |
Suh, TS | 1 |
Linnankivi, T | 1 |
Lundbom, N | 1 |
Autti, T | 1 |
Häkkinen, AM | 1 |
Koillinen, H | 1 |
Kuusi, T | 1 |
Lönnqvist, T | 1 |
Sainio, K | 1 |
Valanne, L | 1 |
Aärimaa, T | 1 |
Pihko, H | 1 |
Tornos, ME | 1 |
Sacristán, A | 1 |
Ortiz, JA | 1 |
Svedmyr, K | 1 |
Mellstrand, T | 1 |
Svedmyr, N | 1 |
Bessho, T | 1 |
Takashina, K | 1 |
Tabata, R | 1 |
Ohshima, C | 1 |
Chaki, H | 1 |
Yamabe, H | 1 |
Egawa, M | 1 |
Tobe, A | 1 |
Saito, K | 1 |
Haubrich, DR | 1 |
Pflueger, AB | 1 |
Zharkovskiĭ, AM | 1 |
Langel, IuL | 1 |
Chereshka, KS | 1 |
Zharkovskaia, TA | 1 |
Engström, C | 1 |
Undén, A | 1 |
Ladinsky, H | 1 |
Consolo, S | 1 |
Bartfai, T | 1 |
Palacios, JM | 1 |
Bolliger, G | 1 |
Closse, A | 1 |
Enz, A | 1 |
Gmelin, G | 1 |
Malanowski, J | 1 |
Saligaut, C | 1 |
Daoust, M | 1 |
Chadelaud, M | 1 |
Moore, N | 1 |
Chretien, P | 1 |
Boismare, F | 1 |
Van Woert, MH | 1 |
Sethy, VH | 1 |
Ambani, LM | 1 |
Pleul, O | 1 |
Rogers, KJ | 1 |
Slater, P | 1 |
1 trial available for choline and Tremor
Article | Year |
---|---|
Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation.
Topics: Administration, Intranasal; Administration, Oral; Asthma; Biological Availability; Bronchodilator Ag | 1982 |
14 other studies available for choline and Tremor
Article | Year |
---|---|
Choline transporter-like 1 deficiency causes a new type of childhood-onset neurodegeneration.
Topics: Adolescent; Antigens, CD; Ataxia; Atrophy; Cerebellum; Choline; Cognitive Dysfunction; Cytoplasmic V | 2020 |
Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study.
Topics: Aged; Aspartic Acid; Choline; Creatine; Discriminant Analysis; Dopamine Plasma Membrane Transport Pr | 2017 |
Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy.
Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Mal | 2003 |
Five new cases of a recently described leukoencephalopathy with high brain lactate.
Topics: Adolescent; Aspartic Acid; Ataxia; Brain Chemistry; Brain Diseases, Metabolic; Brain Stem; Central N | 2004 |
Pharmacological study of oral CDP-choline. Interaction with oxotremorine on the parasympathetic system.
Topics: Animals; Body Temperature; Choline; Cytidine Diphosphate Choline; Diarrhea; Drug Interactions; Femal | 1983 |
Effect of the novel high affinity choline uptake enhancer 2-(2-oxopyrrolidin-1-yl)-N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b] quinolin-4-yl)acetoamide on deficits of water maze learning in rats.
Topics: Acetylcholinesterase; Animals; Aziridines; Body Temperature; Choline; Hippocampus; In Vitro Techniqu | 1996 |
Choline administration: central effect mediated by stimulation of acetylcholine synthesis.
Topics: Acetylcholine; Animals; Atropine; Brain; Choline; Corpus Striatum; Homovanillic Acid; Male; Physosti | 1979 |
[Significance of the dopamine-blocking and m-choline-blocking components in the antiapomorphine action of neuroleptics].
Topics: Animals; Antipsychotic Agents; Apomorphine; Arecoline; Choline; Dopamine Antagonists; Female; Male; | 1987 |
BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies.
Topics: Acetylcholine; Animals; Body Temperature; Brain; Choline; Dose-Response Relationship, Drug; In Vitro | 1987 |
The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
Topics: Acetylcholine; Animals; Behavior, Animal; Body Temperature; Brain; Cattle; Central Nervous System; C | 1986 |
Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
Topics: Administration, Oral; Animals; Choline; Cytidine Diphosphate Choline; Diarrhea; Female; Hypothermia; | 1985 |
Effect of phenothiazines on central cholinergic activity.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Brain Chemistry; Chlorp | 1974 |
Proceedings: On the action of oxotremorine on the cholinergic system of rat brain.
Topics: Acetylcholine; Acetyltransferases; Animals; Brain; Brain Stem; Cerebral Cortex; Choline; Cholinester | 1974 |
Effects of tremorine, physostigmine and tremor blocking drugs on brain monoamines.
Topics: Animals; Antimetabolites; Atropine; Brain; Choline; Drug Antagonism; Female; Hemicholinium 3; Norepi | 1971 |